JNJ-42165279 | m-entrepreneurship.com

Product Name :
JNJ-42165279

Search keywords :
JNJ-42165279

drugId :
null

Target Vo:
Anandamide amidohydrolase

Target Vo Short Name :
FAAH

Moa_Name:
Anandamide amidohydrolase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Johnson & Johnson Innovative Medicine

Active Company_Name :
Janssen Research & Development Llc

Active Indication_Name:
Autism Spectrum Disorder

In Active Indication_Name:
Anxiety

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Hsp70 Antibody (YA359)
ATP1A1 Antibody
HMGB1 Antibody: HMGB1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to HMGB1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts